Ambulatory blood pressure adds to explaining benefits of AT-1 receptor blockade in the treatment of left ventricular hypertrophy

Blood Press. 2007;16(6):344-6. doi: 10.1080/08037050701797263.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Aged
  • Aged, 80 and over
  • Angiotensin II Type 1 Receptor Blockers / administration & dosage*
  • Atenolol / administration & dosage*
  • Blood Pressure / drug effects*
  • Blood Pressure Monitoring, Ambulatory*
  • Double-Blind Method
  • Female
  • Humans
  • Hypertension / drug therapy
  • Hypertension / mortality
  • Hypertension / physiopathology
  • Hypertrophy, Left Ventricular* / drug therapy
  • Hypertrophy, Left Ventricular* / mortality
  • Hypertrophy, Left Ventricular* / physiopathology
  • Losartan / administration & dosage*
  • Male
  • Middle Aged
  • Randomized Controlled Trials as Topic
  • Receptor, Angiotensin, Type 1

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Receptor, Angiotensin, Type 1
  • Atenolol
  • Losartan